UK vaccine gambles paid off, while EU caution slowed it

3 weeks ago

SAINT-HERBLAIN, France (AP) — French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate. The buyer? The United Kingdom — not the European Union, as might be expected for a company on the banks of the Loire. “What a true waste,” bristled Christelle Morancais, president of the Pays de la Loire